全文获取类型
收费全文 | 429篇 |
免费 | 40篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 7篇 |
妇产科学 | 6篇 |
基础医学 | 48篇 |
口腔科学 | 10篇 |
临床医学 | 34篇 |
内科学 | 115篇 |
皮肤病学 | 10篇 |
神经病学 | 60篇 |
特种医学 | 11篇 |
外科学 | 38篇 |
预防医学 | 39篇 |
眼科学 | 11篇 |
药学 | 19篇 |
肿瘤学 | 65篇 |
出版年
2023年 | 4篇 |
2022年 | 9篇 |
2021年 | 24篇 |
2020年 | 13篇 |
2019年 | 19篇 |
2018年 | 25篇 |
2017年 | 19篇 |
2016年 | 14篇 |
2015年 | 12篇 |
2014年 | 17篇 |
2013年 | 25篇 |
2012年 | 40篇 |
2011年 | 31篇 |
2010年 | 20篇 |
2009年 | 25篇 |
2008年 | 27篇 |
2007年 | 35篇 |
2006年 | 30篇 |
2005年 | 34篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 11篇 |
2001年 | 1篇 |
2000年 | 3篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
排序方式: 共有473条查询结果,搜索用时 18 毫秒
31.
32.
Gessamí Sánchez-Ollé Joana Duque Meritxell Egido-Gabás Josefina Casas Montserrat Lluch Amparo Chabás Daniel Grinberg Lluïsa Vilageliu 《Blood cells, molecules & diseases》2009,42(2):159-166
Gaucher disease is an autosomal recessive disorder. It is characterized by the accumulation of glucosylceramide in lysosomes of mononuclear phagocyte system, attributable to acid β-glucosidase deficiency. The main consequences of this disease are hepatosplenomegaly, skeletal lesions and, sometimes, neurological manifestations. At sub-inhibitory concentrations, several competitive inhibitors act as chemical chaperones by inducing protein stabilization and increasing enzymatic activity. Here we tested two iminosugars (NB-DNJ and NN-DNJ) and four aminocyclitols with distinct degrees of lipophilicity as pharmacological chaperones for glucocerebrosidase (GBA). We report an increase in the activity of GBA using NN-DNJ, NB-DNJ and aminocyclitol 1 in stably transfected cell lines, and an increment with NN-DNJ and aminocyclitol 4 in patient fibroblasts. These results on specific mutations validate the use of chemical chaperones as a therapeutic approach for Gaucher disease. However, the development and analysis of new compounds is required in order to find more effective therapeutic agents that are active on a broader range of mutations. 相似文献
33.
Brain deformations induced by space-occupying lesions may result in unpredictable position and shape of functionally important brain structures. The aim of this study is to propose a method for segmentation of brain structures by deformation of a segmented brain atlas in presence of a space-occupying lesion. Our approach is based on an a priori model of lesion growth (MLG) that assumes radial expansion from a seeding point and involves three steps: first, an affine registration bringing the atlas and the patient into global correspondence; then, the seeding of a synthetic tumor into the brain atlas providing a template for the lesion; finally, the deformation of the seeded atlas, combining a method derived from optical flow principles and a model of lesion growth. The method was applied on two meningiomas inducing a pure displacement of the underlying brain structures, and segmentation accuracy of ventricles and basal ganglia was assessed. Results show that the segmented structures were consistent with the patient's anatomy and that the deformation accuracy of surrounding brain structures was highly dependent on the accurate placement of the tumor seeding point. Further improvements of the method will optimize the segmentation accuracy. Visualization of brain structures provides useful information for therapeutic consideration of space-occupying lesions, including surgical, radiosurgical, and radiotherapeutic planning, in order to increase treatment efficiency and prevent neurological damage. 相似文献
34.
35.
Sáenz Y Ruiz J Zarazaga M Teixidó M Torres C Vila J 《The Journal of antimicrobial chemotherapy》2004,53(3):544-545
36.
37.
Isidro Ferrer Meritxell Aguil García Irene Lpez Gonzlez Daniela Diaz Lucena Aina Roig Villalonga Margarita Carmona Tech Franc Llorens Paula GarciaEsparcia Alejandra MartinezMaldonado Margalida Frau Mendez Benjamín Torrejn Escribano Joan Josep BechSerra Eduard Sabido Carolina de la Torre Gmez Jos Antonio del Rio 《Brain pathology (Zurich, Switzerland)》2018,28(6):965
Aging‐related tau astrogliopathy (ARTAG) is defined by the presence of two types of tau‐bearing astrocytes: thorn‐shaped astrocytes (TSAs) and granular/fuzzy astrocytes in the brain of old‐aged individuals. The present study is focused on TSAs in rare forms of ARTAG with no neuronal tau pathology or restricted to entorhinal and transentorhinal cortices, to avoid bias from associated tauopathies. TSAs show 4Rtau phosphorylation at several specific sites and abnormal tau conformation, but they lack ubiquitin and they are not immunostained with tau‐C3 antibodies which recognize truncated tau at Asp421. Astrocytes in ARTAG have atrophic processes, reduced glial fibrillary acidic protein (GFAP) and increased superoxide dismutase 2 (SOD2) immunoreactivity. Gel electrophoresis and western blotting of sarkosyl‐insoluble fractions reveal a pattern of phospho‐tau in ARTAG characterized by two bands of 68 and 64 kDa, and several middle bands between 35 and 50 kDa which differ from what is seen in AD. Phosphoproteomics of dissected vulnerable regions identifies an increase of phosphorylation marks in a large number of proteins in ARTAG compared with controls. GFAP, aquaporin 4, several serine‐threonine kinases, microtubule associated proteins and other neuronal proteins are among the differentially phosphorylated proteins in ARTAG thus suggesting a hyper‐phosphorylation background that affects several molecules, including many kinases and proteins from several cell compartments and various cell types. Finally, present results show for the first time that tau seeding is produced in neurons of the hippocampal complex, astrocytes, oligodendroglia and along fibers of the corpus callosum, fimbria and fornix following inoculation into the hippocampus of wild type mice of sarkosyl‐insoluble fractions enriched in hyper‐phosphorylated tau from selected ARTAG cases. These findings show astrocytes as crucial players of tau seeding in tauopathies. 相似文献
38.
39.
Hagen B. Huttner Peter D. Schellinger Tobias Struffert Gregor Richter Tobias Engelhorn Teresa Bassemir Mathias Mäurer Meritxell Garcia Stefan Schwab Martin Köhrmann Arnd Doerfler 《Journal of neurology》2009,256(7):1121-1125
In multiple sclerosis (MS) more than 95% of the patients have positive oligoclonal bands (OCB) in the cerebrospinal fluid
(CSF). Previous studies have reported differences between patients with and without OCB mainly with regard to clinical parameters
such as age, gender, disease duration, and clinical severity. However, several MRI characteristics have also been hypothesized
to be distinct, and a varying lesion load in OCB-negative and -positive patients is proposed. In this study, we aimed to evaluate
whether Barkhof’s diagnostic MRI criteria are unequally frequently fulfilled in OCB-negative and -positive MS patients. We
screened our database for all OCB-negative MS patients who had (1) been treated with the diagnosis of a clinical definite
relapsing-remitting MS in our institution as well as (2) undergone CSF analysis and MR brain imaging during hospital stay
between January 2004 and December 2007. Eleven OCB-negative patients were identified who fulfilled these criteria. In a second
step, we carefully matched each of them to two OCB-positive controls according to age, gender, EDSS, and disease duration.
The separate analysis of the several parameters of Barkhof’s criteria revealed a less frequent prevalence of infratentorial
(3/11 vs. 18/22; P = 0.005) and a more frequent occurrence of juxtacortical lesions (10/11 vs. 10/22; P = 0.022) in OCB-negative as compared to OCB-positive patients. The overall fulfillment of the Barkhof criteria did not differ
in OCB-negative and -positive patients (7/11 vs. 16/22; P = 0.696). Further analyses of MRI findings between OCB-negative and -positive MS patients might contribute to a better pathophysiological
understanding of the genesis and evidence of OCB in the CSF of MS patients. 相似文献
40.
Font-Llitjós M Rodríguez-Santiago B Espino M Sillué R Mañas S Gómez L Pérez-Jurado LA Palacín M Nunes V 《European journal of human genetics : EJHG》2009,17(1):71-79
Lysinuric protein intolerance (LPI) is a rare autosomal inherited disease caused by defective cationic aminoacid transport 4F2hc/y(+)LAT-1 at the basolateral membrane of epithelial cells in the intestine and kidney. LPI is a multisystemic disease with a variety of clinical symptoms such as hepatosplenomegaly, osteoporosis, hypotonia, developmental delay, pulmonary insufficiency or end-stage renal disease. The SLC7A7 gene, which encodes the y(+)LAT-1 protein, is mutated in LPI patients. Mutation analysis of the promoter localized in intron 1 and all exons of the SLC7A7 gene was performed in 11 patients from 9 unrelated LPI families. Point mutation screening was performed by exon direct sequencing and a new multiplex ligation probe amplification (MLPA) assay was set up for large rearrangement analysis. Eleven SLC7A7-specific mutations were identified, seven of them were novel: p.L124P, p.C425R, p.R468X, p.Y274fsX21, c.625+1G>C, DelE4-E11 and DelE6-E11. The novel large deletions originated by the recombination of Alu repeats at introns 3 and 5, respectively, with the same AluY sequence localized at the SLC7A7 3' region. The novel MLPA assay is robust and valuable for LPI molecular diagnosis. Our results suggest that genomic rearrangements of SLC7A7 play a more important role in LPI than has been reported, increasing the detection rate from 5.1 to 21.4%. Moreover, the 3' region AluY repeat could be a recombination hot spot as it is involved in 38% of all SLC7A7 rearranged chromosomes described so far. 相似文献